Pharmacological Reviews: 65 (1) (2024)

Kenneth E. Bernstein, Frank S. Ong, Wendell-Lamar B. Blackwell, Kandarp H. Shah, Jorge F. Giani, Romer A. Gonzalez-Villalobos, Xiao Z. Shen and Sebastien Fuchs

Rhian M. Touyz, ASSOCIATE EDITOR, Department of Biomedical Sciences and Department of Pathology and Laboratory Medicine, Cedars-Sinai Medical Center, Los Angeles, California

Gemma E. White, Asif J. Iqbal and David R. Greaves

Christopher J. Garland, ASSOCIATE EDITOR, Sir William Dunn School of Pathology, University of Oxford, Oxford, United Kingdom

Julien Spatazza, Elizabeth Di Lullo, Alain Joliot, Edmond Dupont, Kenneth L. Moya and Alain Prochiantz

Glenda E. Gillies, ASSOCIATE EDITOR, Development and Neuropharmacology Group (J.S., E.D.L., K.L.M., A.P.), and Cell Biology of Homeoproteins Group (A.J., E.D.), College de France, Centre for Interdisciplinary Research in Biology, CNRS UMR 7241/INSERM U1050, Labex Memolife, PSL Research University, Paris, France

Chi-Tso Chiu, Zhifei Wang, Joshua G. Hunsberger and De-Maw Chuang

David R. Sibley, ASSOCIATE EDITOR, Molecular Neurobiology Section, National Institute of Mental Health, National Institutes of Health, Bethesda, Maryland

David H. Overstreet and Gregers Wegener

Lynette C. Daws, ASSOCIATE EDITOR, Department of Psychiatry & Center for Alcohol Studies University of North Carolina at Chapel Hill, Chapel Hill, North Carolina (D.H.O.); Centre for Psychiatric Research Aarhus University & Aarhus University Hospital, Risskov, Denmark (G.W.) and Unit for Drug Research and Development, School of Pharmacy (Pharmacology), North-West University, Potchefstroom, South Africa (G.W.)

Garret D. Stuber and Alex O. Mason

Annette C. Dolphin, ASSOCIATE EDITOR, Departments of Psychiatry & Cell Biology and Physiology, UNC Neuroscience Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Philippe Huot, Tom H. Johnston, James B. Koprich, Susan H. Fox and Jonathan M. Brotchie

David R. Sibley, ASSOCIATE EDITOR, Toronto Western Research Institute, University Health Network, Toronto, Ontario, Canada (P.H., T.H.J, J.B.K, S.H.F., J.M.B.); and Division of Neurology, Movement Disorder Clinic, Toronto Western Hospital, University Health Network, Toronto, Ontario, Canada (P.H., S.H.F.)

John T. Williams, Susan L. Ingram, Graeme Henderson, Charles Chavkin, Mark von Zastrow, Stefan Schulz, Thomas Koch, Christopher J. Evans and MacDonald J. Christie

Annette C. Dolphin, ASSOCIATE EDITOR, Vollum Institute, Oregon Health Sciences University, Portland, Oregon (J.T.W.); Department of Neurologic Surgery, Oregon Health Sciences University, Portland, Oregon (S.L.I.); School of Physiology and Pharmacology, University of Bristol, Bristol, United Kingdom (G.H.); Department of Pharmacology, University of Washington, Seattle, Washington (C.C.); Psychiatry and Pharmacology, University of California at San Francisco, San Francisco, California (M.v.Z.); Institute of Pharmacology and Toxicology, Jena University Hospital, Friedrich Schiller University Jena, Jena, Germany (S.S.); Institute of Pharmacology and Toxicology, University of Magdeburg, Magdeburg, Germany (T.K.); Hatos Center of Neuropharmacology, University of California at Los Angeles (C.J.E.); and Discipline of Pharmacology, University of Sydney, Sydney, New South Wales, Australia (M.J.C.)

M. T. Bardo, J. L. Neisewander and T. H. Kelly

Michael A. Nader, ASSOCIATE EDITOR, Department of Psychology (M.T.B.), Center for Drug Abuse Research Translation (M.T.B., T.H.K.), and Department of Behavioral Science (T.H.K.), University of Kentucky, Lexington, Kentucky; and School of Life Sciences, Arizona State University, Tempe, Arizona (J.L.N.)

Patrick T. Ronaldson and Thomas P. Davis

David R. Sibley, ASSOCIATE EDITOR, Department of Medical Pharmacology, College of Medicine, University of Arizona, Tucson, Arizona

Hywel D. Williams, Natalie L. Trevaskis, Susan A. Charman, Ravi M. Shanker, William N. Charman, Colin W. Pouton and Christopher J. H. Porter

Arthur Christopoulos, ASSOCIATE EDITOR, Drug Delivery, Disposition and Dynamics (H.D.W., N.L.T., W.N.C., C.J.H.P.), Centre for Drug Candidate Optimisation (S.A.C.), and Drug Discovery Biology (C.W.P.), Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Victoria, Australia; and Pfizer Global Research and Development, Groton Laboratories, Groton, Connecticut (R.M.S.)

Andreas Klos, Elisabeth Wende, Kathryn J. Wareham and Peter N. Monk